Powerful Medical’s AI heart attack detection model secures FDA approval
September 7, 2026
Powerful’s Queen of Heart analyses ECG reads to detect STEMI and STEMI-equivalent patterns indicative of acute coronary syndrome.
Powerful’s Queen of Heart analyses ECG reads to detect STEMI and STEMI-equivalent patterns indicative of acute coronary syndrome.
StethO Sense, a new Withings+ service powered by eMurmur® and StethoMe, brings on-demand AI-powered heart sound analysis and breathing pattern insights to BeamO users, allowing families to track changes in heart sounds and breathing patterns early from home.
Medtronic (NYSE: MDT) has secured a CE mark for its Endurant stent graft, removing a treatment warning related to its use in ruptured abdominal aortic aneurysms (AAA).
ROTTERDAM, Netherlands, Sept. 3, 2026 /PRNewswire/ — United Imaging has received CE Mark certification for the uCT SiriuX and uCT SiriuX Ultrix, the world’s first dual wide-coverage computed tomography (CT) family, clearing the systems for commercial availability across Europe.
Heartvue.Proton is designed to streamline cardiovascular MRI evaluation.
New FDA clearances expand Hamamatsu’s FDA-cleared NanoZoomer portfolio with compact benchtop and high-throughput digital pathology solutions.
Beginning October 1, 2026, hospitals using Bayesian’s continuous sepsis monitor can receive additional Medicare reimbursement for eligible inpatient cases, the first reimbursement pathway of its kind for presuspicion sepsis monitoring.
CPETWise automates and standardises CPET workflow, transforming complex physiological data into streamlined processes.
The autonomous triage system’s European market authorisation comes as AI becomes increasingly embedded into the cancer screening paradigm.
Stryker (NYSE: SYK) has announced the first clinical use of SportsSuite Vision using the mixed-reality Apple Vision Pro.